Content area

Abstract

Alzheimer's Drug Discovery Foundation - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Alzheimer's Drug Discovery Foundation (ADDF) is a non-profit organization. It provides research services, clinical trials, pre clinical drug discovery. The foundation offers funds for drug discovery and development research programs in the field of Alzheimer’s disease, related dementias and cognitive aging. The foundation also supports companies that develop drugs to prevent, treat and cure Alzheimer’s disease. ADDF provides funds for pre-clinical research and early-stage clinical trials for new drug targets. The foundation partners with various universities among other research and development organizations. ADDF is headquartered in New York, the US

Alzheimer's Drug Discovery Foundation - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

Details

1007133
Company / organization
Title
Alzheimer's Drug Discovery Foundation
Publication title
Number of pages
73
Publication year
2025
Publication date
2025
Publisher
GlobalData plc
Place of publication
London
Country of publication
United Kingdom
Publication subject
Source type
Report
Language of publication
English
Document type
Company Report
Document feature
Mergers & acquisitions
ProQuest document ID
2567941579
Document URL
https://www.proquest.com/reports/alzheimers-drug-discovery-foundation/docview/2567941579/se-2?accountid=208611
Copyright
Copyright GlobalData plc 2025
Last updated
2025-11-14
Database
ProQuest One Academic